In this section
Data is submitted annually to the NHS Newborn Blood Spot Screening Programme regarding performance of the regional newborn blood spot programme in relation to key process and clinical referral standards.
Additionally data regarding blood spot quality and total ‘avoidable repeats’ is reported monthly to the NHS Newborn Blood Spot Screening Programme.
Performance data is also collated quarterly and reports are presented to the Greater Manchester and Lancashire and South Cumbria Quality and Commissioning Groups.
Newborn Screening Laboratory annual reports
Monthly avoidable repeat reports
- October 2020
- November 2020
- December 2020
- January 2021
- February 2021
- March 2021
- April 2021
- May 2021
- June 2021
- July 2021
- August 2021
- September 2021
- October 2021
- November 2021
- December 2021
- January 2022
- February 2022
- March 2022
Quarterly reports
- Quarter 2 2019/20
- Quarter 3 2019/20
- Quarter 4 2019/20
- Quarter 1 2020/21
- Quarter 2 2020/21
- Quarter 3 2020/21
- Quarter 4 2020/21
- Quarter 1 2021/22
- Quarter 2 2021/22
- Quarter 3 2021/22
Other reports/audits
- Postal audit by Helen Jopling, December 2012
- Blood spot sample quality project by Laura Hamilton, April 2013
- Sickle Screening Turnaround Time Re-audit by Suzanne Armitage, May 2014
- Carriers of abnormal haemoglobins – result communication audit by Helen Jopling, November 2014
- Audit of the linkage of antenatal and newborn screening results in the Sickle Cell and Thalassaemia Screening Programme in Greater Manchester, Lancashire and South Cumbria, May 2018
(Last reviewed March 2022)